Related Experiment Videos
Ocular complications with high-dose interferon alpha in chronic active hepatitis
S Kadayifcilar1, S Boyacioglu, H Kart
1Department of Ophthalmology, Başkent University School of Medicine, Ankara, Turkey.
Eye (London, England)
|August 18, 1999
Summary
Interferon alpha therapy for chronic active hepatitis can cause ocular side effects, including retinopathy. Regular eye monitoring is crucial for patients undergoing this treatment to prevent vision loss.
Area of Science:
- Ophthalmology
- Hepatology
- Pharmacology
Background:
- Interferon alpha is a systemic therapy for various disorders.
- This therapy is known to cause reversible side effects across multiple organ systems.
- Ocular complications associated with interferon alpha therapy require further investigation.
Purpose of the Study:
- To investigate the ocular side effects of interferon alpha therapy in patients with chronic active hepatitis.
- To document the incidence and nature of retinal complications during a one-year treatment period.
Main Methods:
- A cohort of 36 patients with chronic active hepatitis receiving subcutaneous interferon alpha therapy for one year was studied.
- Comprehensive ocular examinations and photographic documentation were conducted monthly.
- Statistical analysis included Fisher's exact chi-squared test and Mann-Whitney U-test.
Main Results:
- Trichomegaly (abnormal eyelash growth) was observed in 2 (6%) patients.
- Retinopathy, characterized by cotton wool spots and splinter hemorrhages, was present in 15 (42%) patients.
Conclusions:
- The study highlights the significant incidence of retinal complications in patients undergoing interferon alpha therapy.
- These findings underscore the importance of regular ophthalmological monitoring to detect and manage potential vision-threatening retinal issues.